Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03981497

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Retrospective and Perspective Analysis of Short, Medium and Long Term Clinical Performance of Patients Undergoing MicrowaveThermal Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Francesco De Cobelli · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to collect data on efficacy and safety of microwave ablation (MWA) used to treat subjects with primary and secondary liver malignancies and renal malignancies. The main question it aims to evaluate the short, medium and long-term clinical course of patients treated with MWA. Participants will not alter their normal clinical and therapeutic practice, due to the observational nature of the study, and all data regarding microwave treatments will be collected (including demographic data). follow their normal clinical and therapeutic path

Detailed description

Observational, retrospective and prospective, monocentric study. The objective is to evaluate the short, medium and long-term clinical course of patients undergoing microwave ablation (MWA) for small renal tumors and primary and secondary liver neoplasms. Evaluation of clinical efficacy (progression free survival),safety and technical outcome of microwave ablation as well as clinical outcome of the procedure will be evaluated.At the end of the follow-up periods, the data collected will be compared with those available in the literature on MWA, cryoablation (CA), radiofrequency ablation (RFA) and surgical resection.

Conditions

Interventions

TypeNameDescription
PROCEDUREMicrowave ablation (MWA)Thermal ablation

Timeline

Start date
2018-02-28
Primary completion
2025-12-31
Completion
2030-12-31
First posted
2019-06-10
Last updated
2024-04-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03981497. Inclusion in this directory is not an endorsement.